Last reviewed · How we verify
NISSEL
NISSEL's mechanism of action is not publicly available.
At a glance
| Generic name | NISSEL |
|---|---|
| Sponsor | PharmaKing |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Unfortunately, there is limited information available on NISSEL's mechanism of action.
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NISSEL CI brief — competitive landscape report
- NISSEL updates RSS · CI watch RSS
- PharmaKing portfolio CI